Precision Antibody Discovery Leveraging Machine Learning

Optimizing Antibody Lead Identification: A High Throughput Sequencing and Synthesis Solution

Antibody engineering techniques, such as phage display, yeast display, and hybridoma technology, have enabled the isolation and optimization of antibodies with high specificity and affinity. Harnessing the specificity and versatility of antibodies for therapies as a delivery vehicle offers a transformative advance for precision medicines.

In this poster we present our advanced end-to-end solution that uses next-generation sequencing, machine learning-based lead prioritization, and optimized antibody expression, which together:

• Consistently elevates the number of diverse leads
• Helps to uncover rare clones with favorable biophysical properties
• Facilitates expedited research and development